• Home
  • About
    • Our Story
    • Competitive Strengths
    • Directors
    • Management
  • Pipeline
  • Technology
  • Therapeutic Areas
    • Acne Vulgaris
    • Rosacea
  • Investors
  • Contact
  • Careers
  • News
  • Partnering

Therapeutic areas

  • theraputic1 Acne Vulgaris
  • theraputic3 Rosacea

Acne Vulgaris

Acne Vulgaris is a common skin disease that affects approximately 40-50 million people in the United States,
according to the american Academy of Dermatology. 

Acne occurs most frequently during childhood and adolescence (affecting 80-85% of all adolescents)
but it may also appear in some individual adults.
   
Acne patients suffer from the appearance of lesions on areas of the body with a large concentration of oil glands, such as the face, chest, neck and back. These lesions can be inflamed (papules, pustules, nodules) and non-inflamed (comedones).
Acne has a profound effect on patients' quality of life: the appearance of lesions may cause psychological disorders such as depression, anxiety and lowered self-esteem of the patient. 
Also, acne lesions may cause permanent scarring.
 
There are four major factors that contribute to the emergence of acne lesions: 
  •  Stimulated sebaceous gland, resulting in excess production of sebum. 
  •  Blockage of hair follicles due to abnormal keratinization.
  •  Proliferation of Propionibacterium acnes (P. acnes) within the clogged hair follicles.
  •  Inflammatory response by a variety of immune cell types.

Acne may be also triggered by factors like stress, excessive sweating, use of oily cosmetic 
products and diet.

Rosacea

​Rosacea is a chronic skin disease that first appears as redness on the cheeks, nose, chin or forehead. In later stages of the disease, the redness becomes more persistent, blood vessels become visible and pimples often appear. In severe cases, thickening and swelling of the nose may occur. Other symptoms that patients may experience are burning, stinging, dry skin, plaques and skin thickening.       
Rosacea affects 16 million people in the United States and 40 million people worldwide, 
according to the National Rosacea Society. It is most prevalent in people aged 20-50 and is more common in women than men. 
 
There are four subtypes of Rosacea:  
  •  Erythematotelangiectatic: Persistent facial redness, visible blood vessels.
  • Papulopostular: Facial redness accompanied by pimples and bumps.   
  • Phymatous: Thickening of facial skin and swelling of the nose.
  • Ocular: Conditions such as dry eye, stinging, tearing, styes, bloodshot eyes A rosacea patient may experience symptoms of several subtypes at the same time. 
 
Apart from physical symptoms, rosacea patients may suffer from low self-esteem, low self-confidence, frustration and embarrassment as a result of their appearance and swollen eyelids.    
The cause of rosacea is not known, but there are plenty of factors that can trigger the disease, such as sun exposure, stress, hot/cold weather, wind, heavy exercise, alcohol, spicy foods and many others.

Who We Are

Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products.

What We Do

  • About Us
  • Technology
  • Pipeline

Get In Touch

  • Contact Us
  • Investors
  • Partnering

Email Alerts

Subscribe to receive updates

© 2016 Sol-Gel Technologies Ltd. All Rights Reserved

Powerd by compie